Created page with "The '''Amending Synthetic Drug Control Act''' is an ALEC model policy introduced on July 29, 2016, finalized on September 12, 2016. The model policy is listed under ALEC's [ht..."
New page
The '''Amending Synthetic Drug Control Act''' is an ALEC model policy introduced on July 29, 2016, finalized on September 12, 2016. The model policy is listed under ALEC's [http://www.sourcewatch.org/index.php/ALEC_Health_and_Human_Services_Task_Force Health and Human Services Task Force].
==ALEC Bill Text==
Summary
Amends ineffective law that simply address the problem of synthetic drugs by passing legislation to make specific chemical formulations of synthetic drugs illegal. These specific chemical formulations become dated quickly. This bill goes after broad base formulations that create or mimic the effect of cannabis or certain controlled substances and thereby helps law enforcement to stay ahead of criminal drug activity. Additionally it addresses weakness in the Analog statute that allows clever distributors to cloak products with an innocuous name in order to insulate themselves by marking packages: “Not For Human Consumption.”
<u>Section 1. Short Title.</u>
Amending Synthetic Drug Control
<u>Section 2. Purpose.</u>
Adds various synthetic drug compounds including various structural classes of those compounds to the list of Schedule I controlled substances. Deletes from the definition of controlled substance analog the requirement that a substance must be intended for human consumption to be considered an analog of a controlled substance with a chemical structure substantially similar to that of a controlled substance in Schedule I or II, or that was specifically designed to produce an effect substantially similar to that of a controlled substance in Schedule I or II.
<u>Section 3. Definition.</u>
(f) “Controlled Substance” means
:(i) a drug, substance, or immediate precursor, or synthetic drug in the Schedules of Article II of this Act or
:(ii) a drug or other substance, or immediate precursor, designated as a controlled substance by the Department through administrative rule. The term does not include distilled spirits, wine, malt beverages, or tobacco, as terms are defined or used in… (Reference local state definitions of terms)
<u>Section 4. Amending Synthetic Drug Control Act.</u>
Sec. 204.
(a) The controlled substances listed in this Section are included in Schedule I.
(b) Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation:
:(1) Acetylmethadol;
::(1.1) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)- 4-piperidinyl]-N-phenylacetamide);
:(2) Allylprodine;
:(3) Alphacetylmethadol, except levo-alphacetylmethadol (also known as levo-alpha- acetylmethadol, levomethadyl acetate, or LAAM);
:(4) Alphameprodine;
:(5) Alphamethadol;
:(6) Alpha-methylfentanyl (N-(1-alpha-methyl-beta-phenyl) ethyl-4-piperidyl) propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N- propanilido) piperidine;
::(6.1) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl- 4-piperidinyl]-N-phenylpropanamide);
:(7) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP);
::(7.1) PEPAP (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine);
:(8) Benzethidine;
:(9) Betacetylmethadol;
::(9.1) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)- 4-piperidinyl]-N-phenylpropanamide);
:(10) Betameprodine;
:(11) Betamethadol;
:(12) Betaprodine;
:(13) Clonitazene;
:(14) Dextromoramide;
:(15) Diampromide;
:(16) Diethylthiambutene;
:(17) Difenoxin;
:(18) Dimenoxadol;
:(19) Dimepheptanol;
:(20) Dimethylthiambutene;
:(21) Dioxaphetylbutyrate;
:(22) Dipipanone;
:(23) Ethylmethylthiambutene;
:(24) Etonitazene;
:(25) Etoxeridine;
:(26) Furethidine;
:(27) Hydroxpethidine;
:(28) Ketobemidone;
:(29) Levomoramide;
:(30) Levophenacylmorphan;
:(31) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)- 4-piperidyl]-N-phenylpropanamide);
::(31.1) 3-Methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl- 4-piperidinyl]-N-phenylpropanamide);
:(32) Morpheridine;
:(33) Noracymethadol;
:(34) Norlevorphanol;
:(35) Normethadone;
:(36) Norpipanone;
::(36.1) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)- 4-piperidinyl]propanamide);
:(37) Phenadoxone;
:(38) Phenampromide;
:(39) Phenomorphan;
:(40) Phenoperidine;
:(41) Piritramide;
:(42) Proheptazine;
:(43) Properidine;
:(44) Propiram;
:(45) Racemoramide;
::(45.1) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl- 4-piperidinyl]-propanamide);
:(46) Tilidine;
:(47) Trimeperidine;
:(48) Beta-hydroxy-3-methylfentanyl (other name: N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]- N-phenylpropanamide).
(c) Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, its salts, isomers and salts of isomers, whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:
:(1) Acetorphine;
:(2) Acetyldihydrocodeine;
:(3) Benzylmorphine;
:(4) Codeine methylbromide;
:(5) Codeine-N-Oxide;
:(6) Cyprenorphine;
:(7) Desomorphine;
:(8) Diacetyldihydromorphine (Dihydroheroin);
:(9) Dihydromorphine;
:(10) Drotebanol;
:(11) Etorphine (except hydrochloride salt);
:(12) Heroin;
:(13) Hydromorphinol;
:(14) Methyldesorphine;
:(15) Methyldihydromorphine;
:(16) Morphine methylbromide;
:(17) Morphine methylsulfonate;
:(18) Morphine-N-Oxide;
:(19) Myrophine;
:(20) Nicocodeine;
:(21) Nicomorphine;
:(22) Normorphine;
:(23) Pholcodine;
:(24) Thebacon.
(d) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic substances, or which contains any of its salts, isomers and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (for the purposes of this paragraph only, the term “isomer” includes the optical, position and geometric isomers):
:(1) 3,4-methylenedioxyamphetamine (alpha-methyl,3,4-methylenedioxyphenethylamine, methylenedioxyamphetamine, MDA);
::(1.1) Alpha-ethyltryptamine (some trade or other names: etryptamine; MONASE; alpha-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl)indole; a-ET; and AET);
:(2) 3,4-methylenedioxymethamphetamine (MDMA);
::(2.1) 3,4-methylenedioxy-N-ethylamphetamine (also known as: N-ethyl-alpha-methyl- 3,4(methylenedioxy) Phenethylamine, N-ethyl MDA, MDE, and MDEA);
:(2.2) N-Benzylpiperazine (BZP);
:::(2.2-1) Trifluoromethylphenylpiperazine (TFMPP);
:(3) 3-methoxy-4,5-methylenedioxyamphetamine, (MMDA);
:(4) 3,4,5-trimethoxyamphetamine (TMA);
:(5) (Blank);
:(6) Diethyltryptamine (DET);
:(7) Dimethyltryptamine (DMT);
::(7.1) 5-Methoxy-diallyltryptamine;
:(8) 4-methyl-2,5-dimethoxyamphetamine (DOM, STP);
:(9) Ibogaine (some trade and other names: 7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy- 6,9-methano-5H-pyrido [1′,2′:1,2] azepino [5,4-b] indole; Tabernanthe iboga);
:(10) Lysergic acid diethylamide;
::(10.1) Salvinorin A;
::(10.5) Salvia divinorum (meaning all parts of the plant presently classified botanically as Salvia divinorum, whether growing or not, the seeds thereof, any extract from any part of that plant, and every compound, manufacture, salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation, derivative mixture, or preparation of that plant, its seeds or extracts);
:(11) 3,4,5-trimethoxyphenethylamine (Mescaline);
:(12) Peyote (meaning all parts of the plant presently classified botanically as Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from any part of that plant, and every compound, manufacture, salts, derivative, mixture, or preparation of that plant, its seeds or extracts);
:(13) N-ethyl-3-piperidyl benzilate (JB 318);
:(14) N-methyl-3-piperidyl benzilate;
::(14.1) N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy-alpha-methyl- 3,4(methylenedioxy)phenethylamine and N-hydroxy MDA);
:(15) Parahexyl; some trade or other names: 3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H- dibenzo (b,d) pyran; Synhexyl;
:(16) Psilocybin;
:(17) Psilocyn;
:(18) Alpha-methyltryptamine (AMT);
:(19) 2,5-dimethoxyamphetamine (2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA);
:(20) 4-bromo-2,5-dimethoxyamphetamine (4-bromo-2,5-dimethoxy-alpha-methylphenethylamine; 4-bromo-2,5-DMA);
::(20.1) 4-Bromo-2,5 dimethoxyphenethylamine. Some trade or other names: 2-(4-bromo- 2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB, 2CB, Nexus;
:(21) 4-methoxyamphetamine (4-methoxy-alpha-methylphenethylamine; paramethoxyamphetamine; PMA);
:(22) (Blank);
:(23) Ethylamine analog of phencyclidine. Some trade or other names: N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE;
:(24) Pyrrolidine analog of phencyclidine. Some trade or other names: 1-(1-phenylcyclohexyl) pyrrolidine, PCPy, PHP;
:(25) 5-methoxy-3,4-methylenedioxy-amphetamine;
:(26) 2,5-dimethoxy-4-ethylamphetamine (another name: DOET);
:(27) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine (another name: TCPy);
:(28) (Blank);
:(29) Thiophene analog of phencyclidine (some trade or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine; 2-thienyl analog of phencyclidine; TPCP; TCP);
:(30) Bufotenine (some trade or other names: 3-(Beta-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; 5-hydroxy-N,N-dimethyltryptamine; N,N-dimethylserotonin; mappine);
:(31) 1-Pentyl-3-(1-naphthoyl)indole Some trade or other names: JWH-018;
:(32) 1-Butyl-3-(1-naphthoyl)indole Some trade or other names: JWH-073;
:(33) 1-[(5-fluoropentyl)-1H-indol-3-yl]- (2-iodophenyl)methanone Some trade or other names: AM-694;
:(34) 2-[(1R,3S)-3-hydroxycyclohexyl]-5- (2-methyloctan-2-yl)phenol Some trade or other names: CP 47,497 and its C6, C8 and C9 homologs;
::(34.5) 2-[(1R,3S)-3-hydroxycyclohexyl]-5- (2-methyloctan-2-yl)phenol), where side chain n=5; and homologues where side chain n=4, 6, or 7; Some trade or other names: CP 47,497;
:(35) (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3- (2-methyloctan-2-yl)-6a,7, 10,10a-tetrahydrobenzo[c]chromen-1-ol Some trade or other names: HU-210;
::(35.5) (6aS,10aS)-9-(hydroxymethyl)-6,6- dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a- tetrahydrobenzo[c]chromen-1-ol, its isomers, salts, and salts of isomers; Some trade or other names: HU-210, Dexanabinol;
:(36) Dexanabinol, (6aS,10aS)-9-(hydroxymethyl)- 6,6-dimethyl-3-(2-methyloctan-2-yl)- 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol Some trade or other names: HU-211;
:(37) (2-methyl-1-propyl-1H-indol- 3-yl)-1-naphthalenyl-methanone Some trade or other names: JWH-015;
:(38) 4-methoxynaphthalen-1-yl- (1-pentylindol-3-yl)methanone Some trade or other names: JWH-081;
:(39) 1-Pentyl-3-(4-methyl-1-naphthoyl)indole Some trade or other names: JWH-122;
:(40) 2-(2-methylphenyl)-1-(1-pentyl- 1H-indol-3-yl)-ethanone Some trade or other names: JWH-251;
:(41) 1-(2-cyclohexylethyl)-3- (2-methoxyphenylacetyl)indole Some trade or other names: RCS-8, BTW-8 and SR-18;
:(42) Any compound structurally derived from 3-(1-naphthoyl)indole or 1H-indol-3-yl- (1-naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl whether or not further substituted in the indole ring to any extent, whether or not substituted in the naphthyl ring to any extent. Examples of this structural class include, but are not limited to, JWH-018, AM-2201, JWH-175, JWH-184, and JWH-185;
:(43) Any compound structurally derived from 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted in the naphthyl ring to any extent. Examples of this structural class include, but are not limited to, JWH-030, JWH-145, JWH-146, JWH-307, and JWH-368;
:(44) Any compound structurally derived from 1-(1-naphthylmethyl)indene by substitution at the 3-position of the indene ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl halide, 1-(N-methyl- 2-piperidinyl)methyl, or 2-(4- morpholinyl)ethyl whether or not further substituted in the indene ring to any extent, whether or not substituted in the naphthyl ring to any extent. Examples of this structural class include, but are not limited to, JWH-176;
:(45) Any compound structurally derived from 3-phenylacetylindole by substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl halide, 1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent, whether or not substituted in the phenyl ring to any extent. Examples of this structural class include, but are not limited to, JWH-167, JWH-250, JWH-251, and RCS-8;
:(46) Any compound structurally derived from 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position of the phenolic ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl halide, 1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, whether or not substituted in the cyclohexyl ring to any extent. Examples of this structural class include, but are not limited to, CP 47, 497 and its C8 homologue (cannabicyclohexanol);
::(46.1) Benzoylindoles: Any compound containing a 3-(benzoyl) indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Examples of this structural class include, but are not limited, to AM-630, AM-2233, AM-694, Pravadoline (WIN 48,098), and RCS-4;
:(47) 3,4-Methylenedioxymethcathinone Some trade or other names: Methylone;
:(48) 3,4-Methyenedioxypyrovalerone Some trade or other names: MDPV;
:(49) 4-Methylmethcathinone Some trade or other names: Mephedrone;
:(50) 4-methoxymethcathinone;
:(51) 4-Fluoromethcathinone;
:(52) 3-Fluoromethcathinone;
:(53) 2,5-Dimethoxy-4-(n)-propylthio- phenethylamine;
:(54) 5-Methoxy-N,N-diisopropyltryptamine;
:(55) Pentedrone;
:(56) 4-iodo-2,5-dimethoxy-N-((2-methoxy phenyl)methyl)-benzeneethanamine (trade or other name: 25I-NBOMe);
:(57) 4-chloro-2,5-dimethoxy-N-[(2-methoxyphenyl) methyl]-benzeneethanamine (trade or other name: 25C-NBOMe);
:(58) 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl) methyl]-benzeneethanamine (trade or other name: 25B-NBOMe); .
:(59) 3-cyclopropoylindole with substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, whether or not further substituted on the indole ring to any extent, whether or not substituted on the cyclopropyl ring to any extent: including but not limited to XLR11, UR144, FUB-144;
:(60) 3-adamantoylindole with substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, whether or not further substituted on the indole ring to any extent, whether or not substituted on the adamantyl ring to any extent: including but not limited to AB-001;
:(61) N-(adamantyl)-indole-3-carboxamide with substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, whether or not further substituted on the indole ring to any extent, whether or not substituted on the adamantyl ring to any extent: including but not limited to APICA/2NE-1, STS-135;
:(62) N-(adamantyl)-indazole-3-carboxamide with substitution at a nitrogen atom of the indazole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, whether or not further substituted on the indazole ring to any extent, whether or not substituted on the adamantyl ring to any extent: including but not limited to AKB48, 5F-AKB48;
:(63) 1H-indole-3-carboxylic acid 8-quinolinyl ester with substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, whether or not further substituted on the indole ring to any extent, whether or not substituted on the quinoline ring to any extent: including but not limited to PB22, 5F-PB22, FUB-PB-22;
:(64) 3-(1-naphthoyl)indazole with substitution at the nitrogen atom of the indazole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, whether or not further substituted on the indazole ring to any extent, whether or not substituted on the naphthyl ring to any extent: including but not limited to THJ-018, THJ-2201;
:(65) 2-(1-naphthoyl)benzimidazole with substitution at the nitrogen atom of the benzimidazole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, whether or not further substituted on the benzimidazole ring to any extent, whether or not substituted on the naphthyl ring to any extent: including, but not limited to FUBIMINA;
:(66) N-(1-amino-3-methyl-1-oxobutan-2-yl) -1H-indazole-3-carboxamide with substitution on the nitrogen atom of the indazole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl halide, 1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, whether or not further substituted on the indazole ring to any extent: including but not limited to AB-PINACA, AB-FUBINACA, AB-CHMINACA;
:(67) N-(1-amino-3,3-dimethyl-1-oxobutan- 2-yl)-1H-indazole-3-carboxamide with substitution on the nitrogen atom of the indazole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl halide, 1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, whether or not further substituted on the indazole ring to any extent: including but not limited to ADB-PINACA, ADB-FUBINACA;
:(68) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)- 1H-indole-3-carboxamide with substitution on the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, whether or not further substituted on the indole ring to any extent: including but not limited to ADBICA, 5F-ADBICA;
:(69) N-(1-amino-3-methyl-1-oxobutan-2-yl)- 1H-indole-3-carboxamide with substitution on the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl halide, 1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, whether or not further substituted on the indole ring to any extent: including but not limited to ABICA, 5F-ABICA;
:(70) Methyl 2-(1H-indazole-3-carboxamido)- 3-methylbutanoate with substitution on the nitrogen atom of the indazole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl halide, 1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, whether or not further substituted on the indazole ring to any extent: including but not limited to AMB, 5F-AMB.
(e) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
:(1) mecloqualone;
:(2) methaqualone; and
:(3) gamma hydroxybutyric acid.
(f) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:
:(1) Fenethylline;
:(2) N-ethylamphetamine;
:(3) Aminorex (some other names: 2-amino-5-phenyl-2-oxazoline; aminoxaphen; 4-5-dihydro-5-phenyl-2-oxazolamine) and its salts, optical isomers, and salts of optical isomers;
:(4) Methcathinone (some other names: 2-methylamino-1-phenylpropan-1-one; Ephedrone; 2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone; N-methylcathinone; methycathinone; Monomethylpropion; UR 1431) and its salts, optical isomers, and salts of optical isomers;
:(5) Cathinone (some trade or other names: 2-aminopropiophenone; alpha-aminopropiophenone; 2-amino-1-phenyl-propanone; norephedrone);
:(6) N,N-dimethylamphetamine (also known as: N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine);
:(7) (+ or -) cis-4-methylaminorex ((+ or -) cis- 4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine);
:(8) 3,4-Methylenedioxypyrovalerone (MDPV).
(g) Temporary listing of substances subject to emergency scheduling. Any material, compound, mixture, or preparation that contains any quantity of the following substances:
:(1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl), its optical isomers, isomers, salts, and salts of isomers;
:(2) N-[1(2-thienyl) methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl), its optical isomers, salts, and salts of isomers.
(h) Synthetic cathinones. Unless specifically excepted, any chemical compound not including bupropion, structurally derived from 2-aminopropan-1-one by substitution at the 1-position with either phenyl, naphthyl, or thiophene ring systems, whether or not the compound is further modified in one or more of the following ways:
:(1) by substitution in the ring system to any extent with alkyl, alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the ring system by one or more other univalent substituents. Examples of this class include, but are not limited to, 3,4-Methylenedioxycathinone (bk-MDA);
:(2) by substitution at the 3-position with an acyclic alkyl substituent. Examples of this class include, but are not limited to, 2-methylamino-1-phenylbutan-1-one (buphedrone); or
:(3) by substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups, or by inclusion of the 2-amino nitrogen atom in a cyclic structure. Examples of this class include, but are not limited to, Dimethylcathinone, Ethcathinone, and a-Pyrrolidinopropiophenone (a-PPP). (Source: P.A. 97-192, eff. 7-22-11; 97-193, eff. 1-1-12; 97-194, eff. 7-22-11; 97-334, eff. 1-1-12; 97-813, eff. 7-13-12; 97-872, eff. 7-31-12; 98-987, eff. 1-1-15.)
<u>Sec (Regarding Manufacture or Delivery of Controlled Synthetic drugs). 401.</u>
Except as authorized by this Act, it is unlawful for any person knowingly to manufacture or deliver, or possess with intent to manufacture or deliver, a controlled substance other than methamphetamine, a counterfeit substance, or a controlled substance analog. A violation of this Act with respect to each of the controlled substances listed herein constitutes a single and separate violation of this Act. For purposes of this Section, “controlled substance analog” or “analog” means a substance which is intended for human consumption, other than a controlled substance, that has a chemical structure substantially similar to that of a controlled substance in Schedule I or II, or that was specifically designed to produce an effect substantially similar to that of a controlled substance in Schedule I or II. Examples of chemical classes in which controlled substance analogs are found include, but are not limited to, the following: phenethylamines, N-substituted piperidines, morphinans, ecgonines, quinazolinones, substituted indoles, and arylcycloalkylamines. For purposes of this Act, a controlled substance analog shall be treated in the same manner as the controlled substance to which it is substantially similar.
<u>Sec. 402 (Regarding Possession of Controlled Synthetic Drugs).</u>
Except as otherwise authorized by this Act, it is unlawful for any person knowingly to possess a controlled or counterfeit substance or controlled substance analog. A violation of this Act with respect to each of the controlled substances listed herein constitutes a single and separate violation of this Act. For purposes of this Section, “controlled substance analog” or “analog” means a substance which is intended for human consumption, other than a controlled substance, that has a chemical structure substantially similar to that of a controlled substance in Schedule I or II, or that was specifically designed to produce an effect substantially similar to that of a controlled substance in Schedule I or II. Examples of chemical classes in which controlled substance analogs are found include, but are not limited to, the following: phenethylamines, N-substituted piperidines, morphinans, ecgonines, quinazolinones, substituted indoles, and arylcycloalkylamines. For purposes ofthis Act, a controlled substance analog shall be treated in the same manner as the controlled substance to which it is substantially similar.
<u>Section 5. Severability clause.</u>
<u>Section 6. Repealer clause.</u>
<u>Section 7. {Insert Effective Date}</u>